(+/-)-2-Amino-2-desoxy-3-O-hexadecyl-glycerol
CAS151312-95-7
(+/-)-2-Amino-2-desoxy-3-O-hexadecyl-glycerol (CAS 151312-95-7, C19H41NO2) is supplied by ChemSigma for research and manufacturing, with specification, analytical methods and batch documentation available on request.
- CAS No.
- 151312-95-7
- Formula
- C19H41NO2
- Mol. weight
- 315.54 g/mol
Chemical Specifications
Identifiers
| CAS number | 151312-95-7 |
|---|---|
| Product name | (+/-)-2-Amino-2-desoxy-3-O-hexadecyl-glycerol |
| Synonyms | (+/-)-2-Amino-2-desoxy-3-O-hexadecyl-glycerol |
| Molecular formula | C19H41NO2 |
| Molecular weight | 315.54 g/mol |
Packaging, Storage & Transport
| Available pack sizes | 5kg, 1kg, 500g, 100g, 50g, 10g |
|---|
Read the current safety data sheet before handling. Packaging can be adapted to the order quantity and destination.
Frequently Asked Questions
What is the CAS number of (+/-)-2-Amino-2-desoxy-3-O-hexadecyl-glycerol?
The CAS Registry Number of (+/-)-2-Amino-2-desoxy-3-O-hexadecyl-glycerol is 151312-95-7. (+/-)-2-Amino-2-desoxy-3-O-hexadecyl-glycerol is also known as (+/-)-2-Amino-2-desoxy-3-O-hexadecyl-glycerol.
What is the molecular formula and molecular weight of (+/-)-2-Amino-2-desoxy-3-O-hexadecyl-glycerol?
The molecular formula of (+/-)-2-Amino-2-desoxy-3-O-hexadecyl-glycerol is C19H41NO2, and its molecular weight is 315.54 g/mol.
How can I request a quotation for (+/-)-2-Amino-2-desoxy-3-O-hexadecyl-glycerol?
Send an inquiry for (+/-)-2-Amino-2-desoxy-3-O-hexadecyl-glycerol (CAS 151312-95-7) with the required quantity, target specification, destination country and any documentation requirements. ChemSigma will confirm availability, packaging, lead time and price.
Request a Quote for (+/-)-2-Amino-2-desoxy-3-O-hexadecyl-glycerol
Tell us the required quantity, target specification, destination country and any documentation requirements. We will confirm availability, packaging, lead time and price.
Need custom synthesis or scale-up? Our group company CKS Technology offers custom synthesis, process development and scale-up.